Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2005
09/28/2005EP1578732A2 Pyrimidine derivatives for the treatment of abnormal cell growth
09/28/2005EP1578728A1 5-aminophenanthridine derivatives as npy-5 antagonists
09/28/2005EP1578727A2 Tetrahydroquinoline derivatives and their use as fsh receptor modulators
09/28/2005EP1578726A2 Tetrahydroquinoline derivatives
09/28/2005EP1578724A2 Mitotic kinesin inhibitors
09/28/2005EP1578425A1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
09/28/2005EP1578417A1 1,5-diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators
09/28/2005EP1448521B1 Derivatives of andrimide and moiramide b having antibacterial properties
09/28/2005EP1397348B1 Factor xa inhibitor
09/28/2005EP1307430B1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
09/28/2005EP1286987B1 Heterocyclic hydrazones for use as anti-cancer agents
09/28/2005EP1243583B1 Heterocyclic compounds having sulfonamide groups
09/28/2005EP1165510B1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
09/28/2005EP1163227B1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
09/28/2005EP1086099B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
09/28/2005EP0963200B1 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
09/28/2005CN1675203A Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
09/28/2005CN1675201A N-substituted piperidine derivatives as serotonin receptor agents
09/28/2005CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
09/28/2005CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics
09/28/2005CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase
09/28/2005CN1675195A Inhibitors of tyrosine kinases
09/28/2005CN1675194A Novel aryl-{4-halo-4-[heteroarylmethylamino)-methyl]-piperidin-1-yl}-methanone derivatives, methods for production and use thereof as medicaments
09/28/2005CN1675193A Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridyl-n-2-hydroxycarbonylethyl)-amide
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
09/28/2005CN1674906A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
09/28/2005CN1674904A Process for hydroxyazapirones
09/28/2005CN1674902A Novel crystalline forms of gatifloxacin
09/28/2005CN1674901A Novel salt and polymorphs of desloratadine hemifumarate
09/28/2005CN1674900A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B secretion
09/28/2005CN1674898A 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections
09/28/2005CN1674895A Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
09/28/2005CN1674892A Hetero biaryl derivatives as matrix metalloproteinase inhibitors
09/28/2005CN1673219A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
09/28/2005CN1673218A Organic electronic material containing hindered amine group and spiro structure unit and its synthesis process
09/28/2005CN1220691C Process for preparing 1 -(3 -hydroxymethyl pyridyl-2) -2-phenyl-4- methyl piperazine
09/28/2005CN1220684C 2, 4, Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/28/2005CN1220682C Heterocycle derivatives inhibiting factor Xa
09/28/2005CN1220681C Indole derivatives as XA factor inhibitors
09/27/2005US6949662 Cis-substituted aminocyclopropane derivative
09/27/2005US6949656 Cyclic amine derivatives and use thereof
09/27/2005US6949646 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases
09/27/2005US6949630 acridine, anthraquinone, azine, azo, azomethine, dioxazine, methine, oxazine and imidazole hair dyes
09/27/2005US6949585 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents
09/27/2005US6949580 Anticancer agents; restenosis; antiinflammatory agents; cardiovascular disorders
09/27/2005US6949579 Central nervous system disorders; antidiabetic agents
09/27/2005US6949577 Drugs such as 5-amino-2-((1-n-propyl-1H-imidazol-4-yl)methyl) pentanoic acid, used as carboxypeptidase inhibitors for prophylaxis of thrombosis, atherosclerosis, adhesions, cancer, scarring, fibrosis and inflammation; bradykinins
09/27/2005US6949574 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
09/27/2005US6949573 Substituted 3-amidopyridine derivatives are useful for treating inflammatory, allergic and respiratory diseases, as well as wounds
09/27/2005US6949572 Antilipemic or antilipolytic agents for treatment of obesity and lipid disorders, S)-N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide
09/27/2005US6949571 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof.
09/27/2005US6949570 Carboxyalkyl substituted sulfonamidomethyl amides or ureas used for treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, and diabetes
09/27/2005US6949568 Such as N-(2-(4-(3-phenyl-4-methoxyphenyl)aminophenyl)ethyl)-2-hydroxy-2-(3 -hydroxymethyl-4-hydroxyphenyl)ethylamine; for treatment of chronic obstructive pulmonary disease
09/27/2005US6949565 Protein kinase inhibitors
09/27/2005US6949564 NPY-5 antagonists
09/27/2005US6949554 Calcium channel blockers comprising two benzhydril moieties
09/27/2005US6949551 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides
09/27/2005US6949550 Substituted amino methyl factor Xa inhibitors
09/27/2005US6949547 Antidiabetic agents; central nervous system disorders; cardiovascular disorders; hypotensive agents; anticancer agents
09/27/2005US6949546 N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity
09/27/2005US6949545 Tissue remodeling; antiinflammatory agents; autoimmune disease
09/27/2005US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
09/27/2005US6949542 Dihydro-benzo[b][1,4]diazepin-2-one derivatives
09/27/2005US6949541 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
09/27/2005US6949539 Antiinflammatory agents; autoimmune disease; rheumatic disorders
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/22/2005WO2005087764A1 Tetrahydrobenzazepine derivatives as modulators of dopamine d3 receptors (antipsychotic agents)
09/22/2005WO2005087761A1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
09/22/2005WO2005087760A1 Vla-4 antagonists
09/22/2005WO2005087759A1 Qiunolin-4-ones as inhibitors of retroviral integrase for the treatment of hiv, aids and aids related complex (arc)
09/22/2005WO2005087750A1 Ion channel modulators
09/22/2005WO2005087749A1 2-aminoquinazoline derivative
09/22/2005WO2005087748A1 Ion channel modulators
09/22/2005WO2005087747A1 Ion channel modulators
09/22/2005WO2005087746A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
09/22/2005WO2005087745A1 Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/22/2005WO2005087743A1 Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1r inhibitors
09/22/2005WO2005087740A1 Fluorenone 1, 4,-dihydropyridin derivatives
09/22/2005WO2005087733A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087732A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087727A1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
09/22/2005WO2005087724A2 Sulphonylpyrroles as hdac inhibitors
09/22/2005WO2005087721A2 Compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087237A1 Fasudil-containing preparation and method of improving stability thereof
09/22/2005WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists
09/22/2005WO2005087235A1 Pyrrolidine compounds
09/22/2005WO2005087229A1 Ion channel modulators
09/22/2005WO2005087228A1 Ion channel modulators
09/22/2005WO2005087227A1 Arylalkylamino-substituted quinazoline analogues
09/22/2005WO2005086895A2 Ion channel modulators
09/22/2005WO2005086892A2 Ion channel modulators
09/22/2005WO2005086871A2 Compounds, compositions and methods for inhibiting or treating hiv-1
09/22/2005WO2005086844A2 Magnetism to control friction checks for rods
09/22/2005WO2005086656A2 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
09/22/2005WO2005072681A3 Vanilloid receptor ligands and their use in treatments of inflammatory and neurotic pain.
09/22/2005WO2005056547A3 Quinoxalines useful as inhibitors of protein kinases
09/22/2005WO2005016876A3 Cyclic amine bace-1 inhibitors having a benzamide substituent
09/22/2005WO2004089308A3 Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5
1 ... 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 ... 1080